Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liebermann, D. A.
Right arrow Articles by Hoffman, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liebermann, D. A.
Right arrow Articles by Hoffman, B.

Stem Cells, Vol 12, 352-369, Copyright © 1994 by AlphaMed Press


REVIEWS

Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation

DA Liebermann and B Hoffman
Fels Institute for Cancer Research and Molecular Biology, Temple University, School of Medicine, Philadelphia, Pennsylvania 19140.

By genetically manipulating hematopoietic cells of the myeloid lineage, including both normal cells and differentiation inducible leukemic cell lines, evidence was obtained to indicate that myeloid differentiation primary response (MyD) genes and proto-oncogenes, which are known to control cell growth, function as positive and negative regulators of terminal hematopoietic cell differentiation, which is associated with inhibition of cell growth, and, ultimately programmed cell death (apoptosis). Interferon regulatory factor-1 (IRF-1), an MyD gene induced by Interleukin 6 (IL-6) or Leukemia Inhibitory factor (LIF), plays a role in growth inhibition associated with terminal differentiation. Leucine zipper transcription factors of the fos/jun family, also identified as MyD genes, function as positive regulators of hematopoietic cell differentiation, increasing the propensity of myeloblastic leukemia cells to be induced for differentiation in vitro, and reducing the aggressiveness of their leukemic phenotype in vivo. The zinc finger transcription factor EGR-1, an MyD gene specifically induced upon macrophage differentiation, was shown to be essential for and to restrict differentiation along the macrophage lineage. Finally, evidence has been accumulating to indicate that the novel MyD genes-- MyD116, MyD118 and gadd45 (a member in the MyD118 gene family)--play a role in growth arrest and apoptosis of hematopoietic cells, as well as other cell types. The proto-oncogenes c-myc and c-myb, known to regulate cellular growth, were shown to function as negative regulators of terminal differentiation. Both c-myc and c-myb are normally expressed in proliferating myeloblasts and suppressed following induction of differentiation. Deregulated and continuous expression of c-myc was shown to block terminal myeloid differentiation at an intermediate stage in the progression from immature blasts to mature macrophages, whereas deregulated and continuous expression of c-myb blocked the terminal differentiation program at the immature myeloblast stage. By manipulating myc function in conditional (differentiation inducible) mutant myeloblastic leukemia cell lines, expressing a chimeric mycer transgene, it was shown that there is a window during myeloid differentiation, after the addition of the differentiation inducer, when the terminal differentiation program switches from being dependent on c-myc suppression to becoming c-myc suppression independent, and where activation of c-myc has no apparent effect on mature macrophages. These myeloblastic leukemia cell lines provide a powerful tool to increase our understanding of the role of c-myc in normal hematopoiesis and in leukemogenesis, while also providing a strategy to clone myc target genes.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
C. Grant, P. Jain, M. Nonnemacher, K. E. Flaig, B. Irish, J. Ahuja, A. Alexaki, T. Alefantis, and B. Wigdahl
AP-1-directed human T cell leukemia virus type 1 viral gene expression during monocytic differentiation
J. Leukoc. Biol., September 1, 2006; 80(3): 640 - 650.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
X. Wang, H. Hisha, S. Taketani, Y. Adachi, Q. Li, W. Cui, Y. Cui, J. Wang, C. Song, T. Mizokami, et al.
Characterization of Mesenchymal Stem Cells Isolated from Mouse Fetal Bone Marrow
Stem Cells, March 1, 2006; 24(3): 482 - 493.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
X. Wang, H. Hisha, S. Taketani, M. Inaba, Q. Li, W. Cui, C. Song, T. Fan, Y. Cui, K. Guo, et al.
Neural Cell Adhesion Molecule Contributes to Hemopoiesis-Supporting Capacity of Stromal Cell Lines
Stem Cells, September 1, 2005; 23(9): 1389 - 1399.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Krishnaraju, B. Hoffman, and D. A. Liebermann
Early growth response gene 1 stimulates development of hematopoietic progenitor cells along the macrophage lineage at the expense of the granulocyte and erythroid lineages
Blood, March 1, 2001; 97(5): 1298 - 1305.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
K. Sugiura, H. Hisha, J. Ishikawa, Y. Adachi, S. Taketani, S. Lee, T. Nagahama, and S. Ikehara
Major Histocompatibility Complex Restriction Between Hematopoietic Stem Cells and Stromal Cells In Vitro
Stem Cells, January 1, 2001; 19(1): 46 - 58.
[Abstract] [Full Text]


Home page
BloodHome page
A. Amanullah, B. Hoffman, and D. A. Liebermann
Deregulated E2F-1 blocks terminal differentiation and loss of leukemogenicity of M1 myeloblastic leukemia cells without abrogating induction of p15INK4B and p16INK4A
Blood, July 15, 2000; 96(2): 475 - 482.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. Yu, C. Angelin-Duclos, J. Greenwood, J. Liao, and K. Calame
Transcriptional Repression by Blimp-1 (PRDI-BF1) Involves Recruitment of Histone Deacetylase
Mol. Cell. Biol., April 1, 2000; 20(7): 2592 - 2603.
[Abstract] [Full Text]


Home page
BloodHome page
K. Krishnaraju, B. Hoffman, and D. A. Liebermann
The Zinc Finger Transcription Factor Egr-1 Activates Macrophage Differentiation in M1 Myeloblastic Leukemia Cells
Blood, September 15, 1998; 92(6): 1957 - 1966.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Willems, D. R. Van Bockstaele, F. Lardon, M. Lenjou, G. Nijs, H.-W. Snoeck, Z. N. Berneman, and H. Slegers
Decrease in Nucleoside Diphosphate Kinase (NDPK/nm23) Expression during Hematopoietic Maturation
J. Biol. Chem., May 29, 1998; 273(22): 13663 - 13668.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
B. Tong, H. L. Grimes, T.-Y. Yang, S. E. Bear, Z. Qin, K. Du, W. S. El-Deiry, and P. N. Tsichlis
The Gfi-1B Proto-Oncoprotein Represses p21WAF1 and Inhibits Myeloid Cell Differentiation
Mol. Cell. Biol., May 1, 1998; 18(5): 2462 - 2473.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
B. S. Lee, I. Krits, M. K. Crane-Zelkovic, and S. L. Gluck
A Novel Transcription Factor Regulates Expression of the Vacuolar H+-ATPase B2 Subunit through AP-2 Sites during Monocytic Differentiation
J. Biol. Chem., January 3, 1997; 272(1): 174 - 181.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Azam, M. Vairapandi, W. Zhang, B. Hoffman, and D. A. Liebermann
Interaction of CR6 (GADD45gamma ) with Proliferating Cell Nuclear Antigen Impedes Negative Growth Control
J. Biol. Chem., January 19, 2001; 276(4): 2766 - 2774.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.epitomics.com
Copyright © 1994 by AlphaMed Press.